Straightforward synthesis of a novel ring-fused pyrazole-lactam and in vitro cytotoxic activity on cancer cell lines

  • Eur J Med Chem. 2016 Jul 19:117:1-7. doi: 10.1016/j.ejmech.2016.04.006.
G Bertuzzi  1 E Locatelli  1 D Colecchia  2 P Calandro  3 B F Bonini  1 J Z Chandanshive  1 A Mazzanti  1 P Zani  1 M Chiariello  2 M Comes Franchini  4
Affiliations
  • 1. Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento, 40136, Bologna, Italy.
  • 2. Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), Siena, Italy; IstitutoToscanoTumori (ITT), Core Research Laboratory (CRL), AOU Senese, Italy.
  • 3. IstitutoToscanoTumori (ITT), Core Research Laboratory (CRL), AOU Senese, Italy; Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Italy.
  • 4. Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento, 40136, Bologna, Italy. Electronic address: [email protected].
Abstract

In this paper a straightforward synthesis of a novel pyrazole derivative is reported. Prominent feature of this synthetic process is a 1,3-Dipolar Cycloaddition of a suitable nitrile imine with an activated α,β-unsaturated lactam to afford directly and regioselectively the corresponding ring-fused pyrazole. Having obtained the central core of the synthetic target, a double stepwise functionalization with a "side chain" characterized by a terminal cyclic aliphatic amine was carried out. This molecular structure was designed to interact strongly with typical biological residues, and indeed it showed potent Anticancer capability: in vitro cytotoxicity test on five different Cancer cell lines showed interesting IC50 values in the range of 15-60 μM for exposure time of 24-72 h, thus resulting comparable with commercially available and nowadays therapeutically exploited Anticancer compounds, such as 5-FU and NVP-BEZ235.

Keywords
1,3-Dipolar cycloaddition; Anticancer drug; Lactam; Pyrazole.